Annual Cash & Cash Equivalents
$9.14 M
-$9.85 M-51.87%
December 31, 2023
Summary
- As of February 7, 2025, VRPX annual cash & cash equivalents is $9.14 million, with the most recent change of -$9.85 million (-51.87%) on December 31, 2023.
- During the last 3 years, VRPX annual cash & cash equivalents has risen by +$9.09 million (+16581.57%).
- VRPX annual cash & cash equivalents is now -75.19% below its all-time high of $36.84 million, reached on December 31, 2021.
Performance
VRPX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$17.20 K
-$1.85 M-99.08%
September 30, 2024
Summary
- As of February 7, 2025, VRPX quarterly cash and cash equivalents is $17.20 thousand, with the most recent change of -$1.85 million (-99.08%) on September 30, 2024.
- Over the past year, VRPX quarterly cash and cash equivalents has dropped by -$12.14 million (-99.86%).
- VRPX quarterly cash and cash equivalents is now -99.96% below its all-time high of $41.71 million, reached on September 30, 2021.
Performance
VRPX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VRPX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -51.9% | -99.9% |
| 3 y3 years | +10000.0% | -100.0% |
| 5 y5 years | +10000.0% | -100.0% |
VRPX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -75.2% | at low | -100.0% | at low |
| 5 y | 5-year | -75.2% | >+9999.0% | -100.0% | at low |
| alltime | all time | -75.2% | >+9999.0% | -100.0% | at low |
Virpax Pharmaceuticals Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $17.20 K(-99.1%) |
| Jun 2024 | - | $1.87 M(+0.2%) |
| Mar 2024 | - | $1.87 M(-79.6%) |
| Dec 2023 | $9.14 M(-51.9%) | $9.14 M(-24.8%) |
| Sep 2023 | - | $12.15 M(-17.9%) |
| Jun 2023 | - | $14.80 M(-12.9%) |
| Mar 2023 | - | $16.99 M(-10.6%) |
| Dec 2022 | $19.00 M | $19.00 M(-7.6%) |
| Sep 2022 | - | $20.56 M(-21.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $26.06 M(-15.4%) |
| Mar 2022 | - | $30.80 M(-16.4%) |
| Dec 2021 | $36.84 M(>+9900.0%) | $36.84 M(-11.7%) |
| Sep 2021 | - | $41.71 M(+298.5%) |
| Jun 2021 | - | $10.47 M(-14.7%) |
| Mar 2021 | - | $12.26 M(>+9900.0%) |
| Dec 2020 | $54.80 K(+32.0%) | $54.80 K(-78.6%) |
| Sep 2020 | - | $256.50 K(+518.1%) |
| Dec 2019 | $41.50 K(-14.3%) | $41.50 K |
| Dec 2018 | $48.40 K | - |
FAQ
- What is Virpax Pharmaceuticals annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual cash & cash equivalents year-on-year change?
- What is Virpax Pharmaceuticals quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
What is Virpax Pharmaceuticals annual cash & cash equivalents?
The current annual cash & cash equivalents of VRPX is $9.14 M
What is the all time high annual cash & cash equivalents for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual cash & cash equivalents is $36.84 M
What is Virpax Pharmaceuticals annual cash & cash equivalents year-on-year change?
Over the past year, VRPX annual cash & cash equivalents has changed by -$9.85 M (-51.87%)
What is Virpax Pharmaceuticals quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VRPX is $17.20 K
What is the all time high quarterly cash and cash equivalents for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly cash and cash equivalents is $41.71 M
What is Virpax Pharmaceuticals quarterly cash and cash equivalents year-on-year change?
Over the past year, VRPX quarterly cash and cash equivalents has changed by -$12.14 M (-99.86%)